More recently, several studies reporting results for targeted sequencing with cancer-predisposition gene panels, including BARD1, have been published [35,39,40,41,42,43,44,45,46,47,48,49,50,51,52,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73]. The gene discussed is BARD1; the disease is cancer.